Skip to main content
. 2023 Aug 1;43(4):252–261. doi: 10.14639/0392-100X-N2212

Table I.

Clinical and demographic characteristics of the samples.

Phase of the study Type of study Sample clinical characteristics Mean age (range years) Sex
M F
1 Item generation Item generation Patients with OD (n = 20) 53.3 (42-78) 10 10
2 Internal consistency Internal consistency Patients with OD (n = 112) 57.6 (18-87) 53 59
Reliability analysis Test-retest reliability Patients with OD (n = 61) 57.3 (20-82) 30 31
3 Normative data generation Normative data Asymptomatic subjects (n = 303) 54.9 (18-87) 141 162
4 Validity analysis Clinical validity Asymptomatic subjects (n = 303) 54.9 (18-87) 141 163
Patients with OD (n = 112) 57.6 (18-87) 53 59
Concurrent validity (correlation between Brief-IT-QOD and I-SNOT-22 scores) Patients with OD (n = 112) 57.6 (18-87) 53 59
5 Responsiveness analysis Comparison pre- and post-biological therapy Patients with OD (n = 10) 52.2 (41-67) 7 3
Age is reported as mean (range). OD: olfactory dysfunction.